SNDX logo

Syndax Pharmaceuticals (SNDX) Free Cash Flow

Annual FCF

-$274.90 M
-$114.30 M-71.17%

December 31, 2024


Summary


Performance

SNDX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNDXcash flowmetrics:

Quarterly FCF

-$57.39 M
+$4.93 M+7.92%

December 31, 2024


Summary


Performance

SNDX Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNDXcash flowmetrics:

TTM FCF

-$274.90 M
-$16.04 M-6.20%

December 31, 2024


Summary


Performance

SNDX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNDXcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

SNDX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-71.2%+7.9%-6.2%
3 y3 years-1047.9%+7.9%-6.2%
5 y5 years-443.2%+7.9%-6.2%

SNDX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1047.9%at low-157.0%+31.3%-1043.7%at low
5 y5-year-1047.9%at low-157.0%+31.3%-1043.7%at low
alltimeall time-1047.9%at low-157.0%+31.3%-1043.7%at low

Syndax Pharmaceuticals Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2024
-$274.90 M(+71.2%)
-$57.39 M(-7.9%)
-$274.90 M(+6.2%)
Sep 2024
-
-$62.32 M(-13.0%)
-$258.86 M(+7.3%)
Jun 2024
-
-$71.64 M(-14.2%)
-$241.19 M(+17.7%)
Mar 2024
-
-$83.55 M(+102.1%)
-$204.92 M(+27.6%)
Dec 2023
-$160.60 M(+20.1%)
-$41.35 M(-7.4%)
-$160.60 M(+13.0%)
Sep 2023
-
-$44.65 M(+26.2%)
-$142.15 M(+12.8%)
Jun 2023
-
-$35.37 M(-9.8%)
-$126.04 M(-3.8%)
Mar 2023
-
-$39.23 M(+71.3%)
-$130.97 M(-2.0%)
Dec 2022
-$133.68 M(-560.9%)
-$22.89 M(-19.8%)
-$133.68 M(+1227.2%)
Sep 2022
-
-$28.54 M(-29.2%)
-$10.07 M(+55.6%)
Jun 2022
-
-$40.31 M(-3.9%)
-$6.47 M(-166.1%)
Mar 2022
-
-$41.93 M(-141.6%)
$9.79 M(-66.4%)
Dec 2021
$29.00 M(-140.7%)
$100.71 M(-503.7%)
$29.13 M(-133.4%)
Sep 2021
-
-$24.94 M(+3.7%)
-$87.21 M(+8.3%)
Jun 2021
-
-$24.05 M(+6.4%)
-$80.56 M(+3.4%)
Mar 2021
-
-$22.59 M(+44.5%)
-$77.92 M(+9.4%)
Dec 2020
-$71.26 M(+40.8%)
-$15.63 M(-14.6%)
-$71.26 M(+4.2%)
Sep 2020
-
-$18.30 M(-14.5%)
-$68.36 M(+16.7%)
Jun 2020
-
-$21.41 M(+34.4%)
-$58.59 M(+17.9%)
Mar 2020
-
-$15.93 M(+25.1%)
-$49.71 M(-1.8%)
Dec 2019
-$50.61 M(-26.3%)
-$12.73 M(+49.2%)
-$50.61 M(-4.4%)
Sep 2019
-
-$8.53 M(-31.9%)
-$52.94 M(-15.8%)
Jun 2019
-
-$12.53 M(-25.6%)
-$62.88 M(-4.0%)
Mar 2019
-
-$16.83 M(+11.8%)
-$65.51 M(-4.7%)
DateAnnualQuarterlyTTM
Dec 2018
-$68.72 M(+44.8%)
-$15.06 M(-18.5%)
-$68.72 M(+3.5%)
Sep 2018
-
-$18.47 M(+21.9%)
-$66.42 M(+14.2%)
Jun 2018
-
-$15.15 M(-24.4%)
-$58.18 M(+6.1%)
Mar 2018
-
-$20.04 M(+57.0%)
-$54.83 M(+15.5%)
Dec 2017
-$47.45 M(+34.0%)
-$12.76 M(+24.9%)
-$47.45 M(+5.2%)
Sep 2017
-
-$10.22 M(-13.4%)
-$45.11 M(-2.8%)
Jun 2017
-
-$11.80 M(-6.9%)
-$46.39 M(+11.6%)
Mar 2017
-
-$12.67 M(+21.6%)
-$41.55 M(+17.3%)
Dec 2016
-$35.42 M(+1329.9%)
-$10.42 M(-9.4%)
-$35.42 M(+20.8%)
Sep 2016
-
-$11.50 M(+65.2%)
-$29.33 M(+27.4%)
Jun 2016
-
-$6.96 M(+6.5%)
-$23.02 M(+14.8%)
Mar 2016
-
-$6.54 M(+51.1%)
-$20.06 M(+709.8%)
Dec 2015
-$2.48 M(-82.8%)
-$4.33 M(-16.7%)
-$2.48 M(+52.3%)
Sep 2015
-
-$5.20 M(+29.8%)
-$1.63 M(-268.1%)
Jun 2015
-
-$4.00 M(-136.2%)
$967.00 K(-16.9%)
Mar 2015
-
$11.04 M(-417.8%)
$1.16 M(-108.1%)
Dec 2014
-$14.40 M(+96.3%)
-$3.48 M(+33.6%)
-$14.39 M(+5.0%)
Sep 2014
-
-$2.60 M(-31.6%)
-$13.70 M(+3.5%)
Jun 2014
-
-$3.80 M(-15.7%)
-$13.24 M(+27.8%)
Mar 2014
-
-$4.51 M(+62.0%)
-$10.36 M(+41.3%)
Dec 2013
-$7.33 M(-21.1%)
-$2.79 M(+30.5%)
-$7.33 M(+61.3%)
Sep 2013
-
-$2.13 M(+130.3%)
-$4.55 M(+88.5%)
Jun 2013
-
-$927.00 K(-37.6%)
-$2.41 M(+62.4%)
Mar 2013
-
-$1.49 M
-$1.49 M
Dec 2012
-$9.29 M
-
-

FAQ

  • What is Syndax Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Syndax Pharmaceuticals?
  • What is Syndax Pharmaceuticals annual FCF year-on-year change?
  • What is Syndax Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Syndax Pharmaceuticals?
  • What is Syndax Pharmaceuticals quarterly FCF year-on-year change?
  • What is Syndax Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Syndax Pharmaceuticals?
  • What is Syndax Pharmaceuticals TTM FCF year-on-year change?

What is Syndax Pharmaceuticals annual free cash flow?

The current annual FCF of SNDX is -$274.90 M

What is the all time high annual FCF for Syndax Pharmaceuticals?

Syndax Pharmaceuticals all-time high annual free cash flow is $29.00 M

What is Syndax Pharmaceuticals annual FCF year-on-year change?

Over the past year, SNDX annual free cash flow has changed by -$114.30 M (-71.17%)

What is Syndax Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of SNDX is -$57.39 M

What is the all time high quarterly FCF for Syndax Pharmaceuticals?

Syndax Pharmaceuticals all-time high quarterly free cash flow is $100.71 M

What is Syndax Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, SNDX quarterly free cash flow has changed by +$4.93 M (+7.92%)

What is Syndax Pharmaceuticals TTM free cash flow?

The current TTM FCF of SNDX is -$274.90 M

What is the all time high TTM FCF for Syndax Pharmaceuticals?

Syndax Pharmaceuticals all-time high TTM free cash flow is $29.13 M

What is Syndax Pharmaceuticals TTM FCF year-on-year change?

Over the past year, SNDX TTM free cash flow has changed by -$16.04 M (-6.20%)